JUNS
NASDAQ · Pharmaceuticals
Jupiter Neurosciences Inc
$0.37
-0.01 (-2.87%)
Open$0.38
Previous Close$0.38
Day High$0.40
Day Low$0.36
52W High$3.33
52W Low$0.34
Volume—
Avg Volume233.2K
Market Cap12.99M
P/E Ratio—
EPS$-0.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+11,693.3% upside
Current
$0.37
$0.37
Target
$43.93
$43.93
$31.75
$43.93 avg
$69.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.37M | 3.89M | 4.34M |
| Net Income | 924.0K | 896.5K | 1.08M |
| Profit Margin | 21.1% | 23.1% | 24.9% |
| EBITDA | 1.37M | 1.23M | 1.59M |
| Free Cash Flow | 866.3K | 754.2K | 863.0K |
| Rev Growth | +10.8% | +2.3% | +6.5% |
| Debt/Equity | 0.26 | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |